Alane Koki

7.3k total citations · 4 hit papers
38 papers, 6.2k citations indexed

About

Alane Koki is a scholar working on Pharmacology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Alane Koki has authored 38 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 20 papers in Genetics and 12 papers in Psychiatry and Mental health. Recurrent topics in Alane Koki's work include Inflammatory mediators and NSAID effects (31 papers), Estrogen and related hormone effects (20 papers) and Cancer, Stress, Anesthesia, and Immune Response (12 papers). Alane Koki is often cited by papers focused on Inflammatory mediators and NSAID effects (31 papers), Estrogen and related hormone effects (20 papers) and Cancer, Stress, Anesthesia, and Immune Response (12 papers). Alane Koki collaborates with scholars based in United States, France and Canada. Alane Koki's co-authors include Jaime L. Masferrer, B. Mark Woerner, K. Leahy, Andrew J. Dannenberg, Karen Seibert, Robert A. Soslow, Ben S. Zweifel, Kanwar Nasir M. Khan, Steven L. Settle and D A Edwards and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Alane Koki

38 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

2000 1.1k citations Jaime L. Masferrer, K. Leahy et al. PubMed profile →
COX-2 is expressed in human pulmonary, colonic, and mammary tumors

2000 745 citations Robert A. Soslow, Andrew J. Dannenberg et al. Cancer profile →
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

1999 603 citations Olga Tucker, Andrew J. Dannenberg et al. PubMed profile →
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

1999 602 citations Eun Kyung Yang, Robert A. Soslow et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alane Koki United States	25	3.8k	2.2k	1.6k	1.1k	1.1k	38	6.2k
Raymond N. DuBois United States	8	4.1k 1.1×	2.1k 1.0×	1.4k 0.9×	1.1k 1.0×	1.2k 1.2×	8	6.0k
Stacia Kargman Canada	32	3.6k 0.9×	1.9k 0.9×	1.8k 1.2×	854 0.8×	906 0.9×	53	6.5k
Hongmiao Sheng United States	37	3.2k 0.8×	2.0k 0.9×	2.4k 1.5×	1.4k 1.2×	1.2k 1.1×	56	6.1k
B. Mark Woerner United States	20	2.6k 0.7×	1.5k 0.7×	1.3k 0.8×	1.1k 1.0×	711 0.7×	21	4.8k
Sunao Kawano Japan	39	3.3k 0.9×	1.9k 0.8×	1.8k 1.1×	1.1k 1.0×	1.0k 0.9×	121	7.6k
Joseph Dinchuk United States	15	2.3k 0.6×	1.6k 0.7×	1.2k 0.8×	679 0.6×	655 0.6×	20	4.7k
Dingzhi Wang United States	40	2.1k 0.6×	870 0.4×	2.9k 1.8×	2.0k 1.8×	1.9k 1.7×	64	7.2k
Hiroko Oshima Japan	40	2.2k 0.6×	1.6k 0.7×	4.0k 2.5×	2.2k 1.9×	1.7k 1.6×	87	8.2k
Radhika Aramandla United States	21	2.2k 0.6×	1.8k 0.8×	962 0.6×	650 0.6×	717 0.7×	24	4.2k
Ari Ristimäki Finland	54	3.2k 0.9×	2.5k 1.1×	4.1k 2.6×	3.0k 2.6×	2.0k 1.9×	197	10.6k

Countries citing papers authored by Alane Koki

Since Specialization

Citations

This map shows the geographic impact of Alane Koki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alane Koki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alane Koki more than expected).

Fields of papers citing papers by Alane Koki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alane Koki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alane Koki. The network helps show where Alane Koki may publish in the future.

Co-authorship network of co-authors of Alane Koki

This figure shows the co-authorship network connecting the top 25 collaborators of Alane Koki. A scholar is included among the top collaborators of Alane Koki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alane Koki. Alane Koki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacquemier, Jocelyne, Christophe Ginestier, Jacques Rougemont, et al.. (2005). Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis. Cancer Research. 65(3). 767–779. 174 indexed citations

Birnbaum, Daniel, Patrice Viens, Jocelyne Jacquemier, et al.. (2004). Breast Cancer ProfileChip: from large scale gene expression profiling to oncodiagnostic device. European Journal of Cancer Supplements. 2(3). 99–99. 2 indexed citations

Cervi, David, et al.. (2004). Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib. Oncogene. 23(13). 2305–2314. 7 indexed citations

Bertucci, François, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, et al.. (2004). Identification and validation of an ERBB2 gene expression signature in breast cancers. Oncogene. 23(14). 2564–2575. 101 indexed citations

Koki, Alane, et al.. (2003). Immunohistochemical Analysis of Cyclooxygenase Expression in Human Skin. Humana Press eBooks. 120. 35–43. 1 indexed citations

Wilgus, Traci A., et al.. (2003). Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B–induced skin cancer. Molecular Carcinogenesis. 38(1). 33–39. 41 indexed citations

Wilgus, Traci A., et al.. (2003). Inhibition of cutaneous ultraviolet light B–mediated inflammation and tumor formation with topical celecoxib treatment. Molecular Carcinogenesis. 38(2). 49–58. 136 indexed citations

Abou‐Issa, Hussein, Galal A. Alshafie, Karen Seibert, et al.. (2002). Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.. PubMed. 21(5). 3425–32. 60 indexed citations

Koki, Alane, Nasir Khan, B. Mark Woerner, et al.. (2002). Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(1). 13–18. 42 indexed citations

10.

Koki, Alane & Jaime L. Masferrer. (2002). Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties. Cancer Control. 9(2_suppl). 28–35. 198 indexed citations

11.

López‐Parra, Marta, Joan Clària, Anna Planagumà, et al.. (2002). Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. British Journal of Pharmacology. 135(4). 891–900. 35 indexed citations

12.

Koki, Alane, Nasir Khan, B. Mark Woerner, et al.. (2002). Cyclooxygenase-2 In Human Pathological Disease. Advances in experimental medicine and biology. 507. 177–184. 117 indexed citations

13.

Leahy, K., Alane Koki, & Jaime L. Masferrer. (2000). Role of Cyclooxygenases in Angiogenesis. Current Medicinal Chemistry. 7(11). 1163–1170. 158 indexed citations

14.

Soslow, Robert A., Andrew J. Dannenberg, Demaretta Rush, et al.. (2000). COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 89(12). 2637–2645. 745 indexed citations breakdown →

15.

Sadovsky, Yoel, D. Michael Nelson, Louis J. Muglia, et al.. (2000). Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. American Journal of Obstetrics and Gynecology. 182(2). 370–376. 48 indexed citations

16.

Masferrer, Jaime L., K. Leahy, Alane Koki, et al.. (2000). Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.. PubMed. 60(5). 1306–11. 1110 indexed citations breakdown →

17.

Koki, Alane, K. Leahy, & Jaime L. Masferrer. (1999). Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy. Expert Opinion on Investigational Drugs. 8(10). 1623–1638. 99 indexed citations

18.

Ornberg, Richard & Alane Koki. (1999). Visualization and Quantitation of Cyclooxygenase-1 and -2 Activity by Digital Fluorescence Microscopy.. Advances in experimental medicine and biology. 469. 131–137. 3 indexed citations

19.

Tucker, Olga, Andrew J. Dannenberg, Eun Kyung Yang, et al.. (1999). Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.. PubMed. 59(5). 987–90. 603 indexed citations breakdown →

20.

Mohammed, Sulma I., Richard S. Foster, Nasir Khan, et al.. (1999). EXPRESSION OF CYCLOOXYGENASE (COX) -1 AND COX-2 IN HUMAN INVASIVE TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER. The Journal of Urology. 316–316. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact